Skip to main content
Top
Published in: Journal of Cancer Research and Clinical Oncology 1/2004

01-01-2004 | Original Paper

Enhancement of effects of irradiation by gemcitabine in a glioblastoma cell line and cell line spheroids

Authors: Mine Genç, Natasja Castro Kreder, Angelique Barten-van Rijbroek, Lukas J. A. Stalpers, Jaap Haveman

Published in: Journal of Cancer Research and Clinical Oncology | Issue 1/2004

Login to get access

Abstract

Background and purpose

To determine the cytotoxicity of, and radioenhancement by, gemcitabine on a glioma cell line grown as a monolayer and as spheroid cultures.

Material and methods

We used a human glioma cell line, Gli-6, which originated from a biopsy specimen of a patient with a glioblastoma multiforme. Spheroids of Gli-6 were prepared by seeding a single cell suspension on agarose-coated Petri dishes. Clonogenic and growth delay assays were used to determine radio-chemosensitivity of monolayer cultures. The growth delay assay was used to determine that of Gli-6 spheroid cultures.

Results

Spheroid cultures were found to be more resistant to irradiation with/or without gemcitabine than monolayer cultures. Whereas gemcitabine significantly enhances the radiation effect of exponentially growing Gli-6 monolayer cultures at minimal cytotoxic concentrations (10 nM, 24 h), no enhancement was seen in confluent monolayer cultures and in large spheroids at the same concentration. In small spheroids no enhancement was observed at a low-dose gemcitabine (10 nM for 24 h), but an enhancement was observed at higher concentrations (100 nM for 24 h).

Conclusion

Gemcitabine can lead to enhancement of the effects of X-irradiation in both monolayer as spheroid glioblastoma cultures. The lack of enhancement in confluent monolayer cultures supports the view that cell cycle distribution of cells is important in radiosensitisation by gemcitabine
Literature
go back to reference Arning M, Blatter J (1997) Gemcitabine in solid tumors-present status and further development. Oncologie 29:297–304 Arning M, Blatter J (1997) Gemcitabine in solid tumors-present status and further development. Oncologie 29:297–304
go back to reference Barendsen GW (1982) Radiobiology of neutrons. Int J Radiat Oncol Biol Phys 8:2103–2107PubMed Barendsen GW (1982) Radiobiology of neutrons. Int J Radiat Oncol Biol Phys 8:2103–2107PubMed
go back to reference Barendsen GW, Van Bree C, Franken NA (2001) Importance of cell proliferative state and potentially lethal damage repair on radiation effectiveness: implications for combined tumor treatments. Int J Oncol 19:247–256PubMed Barendsen GW, Van Bree C, Franken NA (2001) Importance of cell proliferative state and potentially lethal damage repair on radiation effectiveness: implications for combined tumor treatments. Int J Oncol 19:247–256PubMed
go back to reference Biaglow JE, Varnes ME, Jacobson B, Koch CJ (1983) Factors influencing the oxygen consumption and radiation response of cultured mammalian cells. Adv Exp Med Biol 159:347–358PubMed Biaglow JE, Varnes ME, Jacobson B, Koch CJ (1983) Factors influencing the oxygen consumption and radiation response of cultured mammalian cells. Adv Exp Med Biol 159:347–358PubMed
go back to reference Bjerkvig R, Tonnesen A, Laerum OD, Backlund EO (1990) Multicellular tumor spheroids from human gliomas maintained in organ culture. J Neurosurg 72:463–475PubMed Bjerkvig R, Tonnesen A, Laerum OD, Backlund EO (1990) Multicellular tumor spheroids from human gliomas maintained in organ culture. J Neurosurg 72:463–475PubMed
go back to reference Buffa FM, West C, Byrne K, Moore JV, Nahum AE (2001) Radiation response and cure rate of human colon adenocarcinoma spheroids of different size: the significance of hypoxia on tumor control modelling. Int J Radiat Oncol Biol Phys 49:1109–1118CrossRefPubMed Buffa FM, West C, Byrne K, Moore JV, Nahum AE (2001) Radiation response and cure rate of human colon adenocarcinoma spheroids of different size: the significance of hypoxia on tumor control modelling. Int J Radiat Oncol Biol Phys 49:1109–1118CrossRefPubMed
go back to reference Carlsson J, Nilsson K, Westermark B, Ponten J, Sundstrom C, Larsson E, Bergh J, Pahlman S, Busch C, Collins VP (1983) Formation and growth of multicellular spheroids of human origin. Int J Cancer 31:523–533PubMed Carlsson J, Nilsson K, Westermark B, Ponten J, Sundstrom C, Larsson E, Bergh J, Pahlman S, Busch C, Collins VP (1983) Formation and growth of multicellular spheroids of human origin. Int J Cancer 31:523–533PubMed
go back to reference Carlsson J, Yuhas JM (1984) Liquid-overlay culture of cellular spheroids. In: Acker H, Carlsson J, Durand R, Sutherland RM (eds) Recent results in cancer research. Spheroids in cancer research. Springer, Berlin, pp 1–23 Carlsson J, Yuhas JM (1984) Liquid-overlay culture of cellular spheroids. In: Acker H, Carlsson J, Durand R, Sutherland RM (eds) Recent results in cancer research. Spheroids in cancer research. Springer, Berlin, pp 1–23
go back to reference Dertinger H, Hulser D (1981) Increased radioresistance of cells in cultured multicell spheroids. I. Dependence on cellular interaction. Radiat Environ Biophys 19:101–107PubMed Dertinger H, Hulser D (1981) Increased radioresistance of cells in cultured multicell spheroids. I. Dependence on cellular interaction. Radiat Environ Biophys 19:101–107PubMed
go back to reference Desoize B, Gimonet D, Jardiller JC (1998) Cell culture as spheroids: an approach to multicellular resistance. Anticancer Res 18:4147–4158PubMed Desoize B, Gimonet D, Jardiller JC (1998) Cell culture as spheroids: an approach to multicellular resistance. Anticancer Res 18:4147–4158PubMed
go back to reference Durand RE, Biaglow JE (1977) Radiosensitization of hypoxic cells of an in vitro tumor model by respiratory inhibitors. Radiat Res 69:359–366PubMed Durand RE, Biaglow JE (1977) Radiosensitization of hypoxic cells of an in vitro tumor model by respiratory inhibitors. Radiat Res 69:359–366PubMed
go back to reference Fehlauer F, Barten-Van Rijbroek AD, Stalpers LJ, Leenstra S, Lindeman J, Tjahja I, Troost D, Wolbers JG, van der Valk P, Sminia P (2000) Additive cytotoxic effect of cisplatin and X-irradiation on human glioma cell cultures derived from biopsy-tissue. J Cancer Res Clin Oncol 126:711–716PubMed Fehlauer F, Barten-Van Rijbroek AD, Stalpers LJ, Leenstra S, Lindeman J, Tjahja I, Troost D, Wolbers JG, van der Valk P, Sminia P (2000) Additive cytotoxic effect of cisplatin and X-irradiation on human glioma cell cultures derived from biopsy-tissue. J Cancer Res Clin Oncol 126:711–716PubMed
go back to reference Gertler SZ, MacDonald D, Goodyear M, Forsyth P, Stewart DJ, Belanger K, Perry J, Fulton D, Steward W, Wainman N, Seymour L (2000) NCIC-CTG phase II study of gemcitabine in patients with malignant glioma (IND.94). Ann Oncol 11:315–318CrossRefPubMed Gertler SZ, MacDonald D, Goodyear M, Forsyth P, Stewart DJ, Belanger K, Perry J, Fulton D, Steward W, Wainman N, Seymour L (2000) NCIC-CTG phase II study of gemcitabine in patients with malignant glioma (IND.94). Ann Oncol 11:315–318CrossRefPubMed
go back to reference Gonzàlez Gonzàlez D, Hulshof MCCM (1993) Radiotherapy. In: Twijnstra A, Keyser A, Ongerboer de Visser BW (eds) Neuro-oncology. Primary tumors and neurological complications of cancer. Elsevier, Amsterdam, pp 134–158 Gonzàlez Gonzàlez D, Hulshof MCCM (1993) Radiotherapy. In: Twijnstra A, Keyser A, Ongerboer de Visser BW (eds) Neuro-oncology. Primary tumors and neurological complications of cancer. Elsevier, Amsterdam, pp 134–158
go back to reference Gorlach A, Acker H (1994) pO2- and pH-gradients in multicellular spheroids and their relationship to cellular metabolism and radiation sensitivity of malignant human tumor cells. Biochim Biophys Acta 1227:105–112PubMed Gorlach A, Acker H (1994) pO2- and pH-gradients in multicellular spheroids and their relationship to cellular metabolism and radiation sensitivity of malignant human tumor cells. Biochim Biophys Acta 1227:105–112PubMed
go back to reference Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100:57–70PubMed Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100:57–70PubMed
go back to reference Hulshof MC, Koot RW, Schimmel EC, Dekker F, Bosch DA, Gonzalez Gonzalez D (2001) Prognostic factors in glioblastoma multiforme. 10 years experience of a single institution. Strahlenther Onkol 177:283–290PubMed Hulshof MC, Koot RW, Schimmel EC, Dekker F, Bosch DA, Gonzalez Gonzalez D (2001) Prognostic factors in glioblastoma multiforme. 10 years experience of a single institution. Strahlenther Onkol 177:283–290PubMed
go back to reference Kaaijk P, Troost D, Das PK, Leenstra S, Bosch DA (1995) Long-term culture of organotypic multicellular glioma spheroids: a good culture model for studying gliomas. Neuropathol Appl Neurobiol 21:386PubMed Kaaijk P, Troost D, Das PK, Leenstra S, Bosch DA (1995) Long-term culture of organotypic multicellular glioma spheroids: a good culture model for studying gliomas. Neuropathol Appl Neurobiol 21:386PubMed
go back to reference Kaaijk P, Troost D, Sminia P, Hulshof MC, van der Kracht AH, Leenstra S, Bosch DA (1997) Hypofractionated radiation induces a decrease in cell proliferation but no histological damage to organotypic multicellular spheroids of human glioblastomas. Eur J Cancer 33:645–651CrossRefPubMed Kaaijk P, Troost D, Sminia P, Hulshof MC, van der Kracht AH, Leenstra S, Bosch DA (1997) Hypofractionated radiation induces a decrease in cell proliferation but no histological damage to organotypic multicellular spheroids of human glioblastomas. Eur J Cancer 33:645–651CrossRefPubMed
go back to reference Kunz-Schughart LA (1999) Multicellular tumor spheroids: intermediates between monolayer culture and in vivotumor. Cell Biol Int 23:157–161CrossRefPubMed Kunz-Schughart LA (1999) Multicellular tumor spheroids: intermediates between monolayer culture and in vivotumor. Cell Biol Int 23:157–161CrossRefPubMed
go back to reference Latz D, Fleckenstein K, Eble M, Blatter J, Wannenmacher M, Weber KJ (1998) Radiosensitizing potential of gemcitabine (2’,2’-difluoro-2’-deoxycytidine) within the cell cycle in vitro. Int J Radiat Oncol Biol Phys 41:875–882CrossRefPubMed Latz D, Fleckenstein K, Eble M, Blatter J, Wannenmacher M, Weber KJ (1998) Radiosensitizing potential of gemcitabine (2’,2’-difluoro-2’-deoxycytidine) within the cell cycle in vitro. Int J Radiat Oncol Biol Phys 41:875–882CrossRefPubMed
go back to reference Lawrence TS, Eisbruch A, Shewach DS (1997) Gemcitabine-mediated radiosensitization. Sem Oncol 24:24−28 Lawrence TS, Eisbruch A, Shewach DS (1997) Gemcitabine-mediated radiosensitization. Sem Oncol 24:24−28
go back to reference Mason KA, Milas L, Hunter NR et al. (1999) Maximizing therapeutic gain with gemcitabine and fractionated radiation. Int J Radiat Oncol Biol Phys 44:1125–1135CrossRefPubMed Mason KA, Milas L, Hunter NR et al. (1999) Maximizing therapeutic gain with gemcitabine and fractionated radiation. Int J Radiat Oncol Biol Phys 44:1125–1135CrossRefPubMed
go back to reference Neshasteh-Riz A, Angerson WJ, Reeves JR, Smith G, Rampling R, Mairs RJ (1997) Incorporation of iododeoxyuridine in multicellular glioma spheroids: implications for DNA-targeted radiotherapy using Auger electron emitters. Br J Cancer 75:493–499PubMed Neshasteh-Riz A, Angerson WJ, Reeves JR, Smith G, Rampling R, Mairs RJ (1997) Incorporation of iododeoxyuridine in multicellular glioma spheroids: implications for DNA-targeted radiotherapy using Auger electron emitters. Br J Cancer 75:493–499PubMed
go back to reference Nirmala C, Rao JS, Ruifrok AC, Langford LA, Obeyesekere M. (2001) Growth characteristics of glioblastoma spheroids. Int J Oncol 19:1109–1115PubMed Nirmala C, Rao JS, Ruifrok AC, Langford LA, Obeyesekere M. (2001) Growth characteristics of glioblastoma spheroids. Int J Oncol 19:1109–1115PubMed
go back to reference Olive PL, Durand RE (1994) Drug and radiation resistance in spheroids: cell contact and kinetics. Cancer Metastasis Rev 13:121–138PubMed Olive PL, Durand RE (1994) Drug and radiation resistance in spheroids: cell contact and kinetics. Cancer Metastasis Rev 13:121–138PubMed
go back to reference Ostruszka LJ, Shewach DS (2000) The role of cell cycle progression in radiosensitization by 2’,2’-difluoro-2’-deoxycytidine. Cancer Res 60:6080–6088PubMed Ostruszka LJ, Shewach DS (2000) The role of cell cycle progression in radiosensitization by 2’,2’-difluoro-2’-deoxycytidine. Cancer Res 60:6080–6088PubMed
go back to reference Plunkett W, Huang P, Gandhi V (1995) Preclinical characteristics of gemcitabine. Anti-Cancer Drugs 6:7–13 Plunkett W, Huang P, Gandhi V (1995) Preclinical characteristics of gemcitabine. Anti-Cancer Drugs 6:7–13
go back to reference Prados MD, Wilson CB (1997) Neoplasms of the central nervous system. In: I. Williams & Wilkins (eds) Cancer medicine. Baltimore, pp 1471–1514 Prados MD, Wilson CB (1997) Neoplasms of the central nervous system. In: I. Williams & Wilkins (eds) Cancer medicine. Baltimore, pp 1471–1514
go back to reference Ramsay J, Ward R, Bleehen NM (1992) Radiosensitivity testing of human malignant gliomas. Int J Radiat Oncol Biol Phys 24:675–680PubMed Ramsay J, Ward R, Bleehen NM (1992) Radiosensitivity testing of human malignant gliomas. Int J Radiat Oncol Biol Phys 24:675–680PubMed
go back to reference Rieger J, Durka S, Streffer J, Dichgans J, Weller M (1999) Gemcitabine cytotoxicity of human malignant glioma cells: modulation by antioxidants, BCL-2 and dexamethasone. Eur J Pharmacol 365:301–308CrossRefPubMed Rieger J, Durka S, Streffer J, Dichgans J, Weller M (1999) Gemcitabine cytotoxicity of human malignant glioma cells: modulation by antioxidants, BCL-2 and dexamethasone. Eur J Pharmacol 365:301–308CrossRefPubMed
go back to reference Santini MT, Rainaldi G, Indovina PL (1999) Multicellular tumour spheroids in radiation biology. Int J Radiat Biol 1999 75:787–799CrossRef Santini MT, Rainaldi G, Indovina PL (1999) Multicellular tumour spheroids in radiation biology. Int J Radiat Biol 1999 75:787–799CrossRef
go back to reference Sminia P, Acker H, Eikesdal HP, Kaaijk P, Enger P, Slotman B, Bjerkvig R (2003) Oxygenation and response to irradiation of organotypic multicellular spheroids of human glioma. Anticancer Res 23:1461–1466PubMed Sminia P, Acker H, Eikesdal HP, Kaaijk P, Enger P, Slotman B, Bjerkvig R (2003) Oxygenation and response to irradiation of organotypic multicellular spheroids of human glioma. Anticancer Res 23:1461–1466PubMed
go back to reference Smitskamp-Wilms E, Pinedo HM, Veerman G, Ruiz van Haperen VWT, Peters GJ (1998) Postconfluent multilayered cell line cultures for selective screening of gemcitabine. Eur J Cancer 34:921–926CrossRefPubMed Smitskamp-Wilms E, Pinedo HM, Veerman G, Ruiz van Haperen VWT, Peters GJ (1998) Postconfluent multilayered cell line cultures for selective screening of gemcitabine. Eur J Cancer 34:921–926CrossRefPubMed
go back to reference Sutherland RM & Durand RE (1973) Hypoxic cells in an in vitro tumour model. Int J Radiat Biol Relat Stud Phys Chem Med 23:235–246PubMed Sutherland RM & Durand RE (1973) Hypoxic cells in an in vitro tumour model. Int J Radiat Biol Relat Stud Phys Chem Med 23:235–246PubMed
go back to reference Sutherland RM (1988) Cell and environment interactions in tumor microregions: the multicell spheroid model. Science 240:177–184PubMed Sutherland RM (1988) Cell and environment interactions in tumor microregions: the multicell spheroid model. Science 240:177–184PubMed
go back to reference Sutherland RM (1998) Tumor hypoxia and gene expression--implications for malignant progression and therapy. Acta Oncol 37:567–574CrossRefPubMed Sutherland RM (1998) Tumor hypoxia and gene expression--implications for malignant progression and therapy. Acta Oncol 37:567–574CrossRefPubMed
go back to reference Taghian A, Ramsay J, Allalunis-Turner J (1993) Intrinsic radiation sensitivity may not be the major determinant of the poor clinical outcome of glioblastoma multiforme. Int J Radiat Oncol Biol Phys 25:243–249PubMed Taghian A, Ramsay J, Allalunis-Turner J (1993) Intrinsic radiation sensitivity may not be the major determinant of the poor clinical outcome of glioblastoma multiforme. Int J Radiat Oncol Biol Phys 25:243–249PubMed
go back to reference Van Bree C, Castro Kreder N, Loves WJ, Franken NA, Peters GJ, Haveman J (2002) Sensitivity to ionizing radiation and chemotherapeutic agents in gemcitabine-resistant human tumor cell lines. Int J Radiat Oncol Biol Phys 54:237–244PubMed Van Bree C, Castro Kreder N, Loves WJ, Franken NA, Peters GJ, Haveman J (2002) Sensitivity to ionizing radiation and chemotherapeutic agents in gemcitabine-resistant human tumor cell lines. Int J Radiat Oncol Biol Phys 54:237–244PubMed
go back to reference Weller M, Streffer J, Wick W. et al (2001) Preirradiation gemcitabine chemotherapy for newly diagnosed glioblastoma. Cancer 91:423–427CrossRefPubMed Weller M, Streffer J, Wick W. et al (2001) Preirradiation gemcitabine chemotherapy for newly diagnosed glioblastoma. Cancer 91:423–427CrossRefPubMed
Metadata
Title
Enhancement of effects of irradiation by gemcitabine in a glioblastoma cell line and cell line spheroids
Authors
Mine Genç
Natasja Castro Kreder
Angelique Barten-van Rijbroek
Lukas J. A. Stalpers
Jaap Haveman
Publication date
01-01-2004
Publisher
Springer-Verlag
Published in
Journal of Cancer Research and Clinical Oncology / Issue 1/2004
Print ISSN: 0171-5216
Electronic ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-003-0506-y

Other articles of this Issue 1/2004

Journal of Cancer Research and Clinical Oncology 1/2004 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.